Adoptive T-Cell Therapy for Cancer in the United Kingdom: A Review of Activity for the British Society of Gene and Cell Therapy
![Frontiers | Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP Frontiers | Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP](https://www.frontiersin.org/files/Articles/828489/fgeed-04-828489-HTML/image_m/fgeed-04-828489-g002.jpg)
Frontiers | Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP
![IJMS | Free Full-Text | Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy | HTML IJMS | Free Full-Text | Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy | HTML](https://www.mdpi.com/ijms/ijms-20-06223/article_deploy/html/images/ijms-20-06223-g001.png)